If extrapolated beyond CD4+ T cells, our results on IL-10 signaling supporting the long-term maintenance of immunological memory may help explain recent data showing that IL-10R signaling favors the maintenance of a population of CD8+ T cells that promote tumor control in oncology models (57). This evidence concerns the gene CD8A and neoplasm.